Literature DB >> 13525216

The toxicity and metabolism of dihydroquercetin.

A N BOOTH, F DEEDS.   

Abstract

Entities:  

Keywords:  VITAMIN P

Mesh：

Substances：

Year:  1958        PMID： 13525216

Source DB:  PubMed          Journal:  J Am Pharm Assoc Am Pharm Assoc


× No keyword cloud information.
  12 in total

1.  Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy.

Authors:  Takayuki Inoue; Satoshi Saito; Masashi Tanaka; Hajime Yamakage; Toru Kusakabe; Akira Shimatsu; Masafumi Ihara; Noriko Satoh-Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

2.  Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.

Authors:  Mizuho Sato; Kazuma Murakami; Mayumi Uno; Yu Nakagawa; Sumie Katayama; Ken-ichi Akagi; Yuichi Masuda; Kiyonori Takegoshi; Kazuhiro Irie
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

3.  The bacterial degradation of flavonoids. Oxidative fission of the A-ring of dihydrogossypetin by a Pseudomonas sp.

Authors:  A M Jeffrey; D M Jerina; R Self; W C Evans
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

4.  Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets.

Authors:  T Yugarani; B K Tan; M Teh; N P Das
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

5.  Inhibitory effects of some natural products on metal-induced lipid oxidation in cooked fish.

Authors:  L Ramanathan; N P Das
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

6.  Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.

Authors:  Satoshi Saito; Yumi Yamamoto; Takakuni Maki; Yorito Hattori; Hideki Ito; Katsuhiko Mizuno; Mariko Harada-Shiba; Raj N Kalaria; Masanori Fukushima; Ryosuke Takahashi; Masafumi Ihara
Journal:  Acta Neuropathol Commun       Date:  2017-04-04       Impact factor: 7.801

7.  Inhibition of HEWL fibril formation by taxifolin: Mechanism of action.

Authors:  Mohsen Mahdavimehr; Ali Akbar Meratan; Maryam Ghobeh; Atiyeh Ghasemi; Ali Akbar Saboury; Mohsen Nemat-Gorgani
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

8.  Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MS(n).

Authors:  Ping Yang; Feng Xu; Hong-Fu Li; Yi Wang; Feng-Chun Li; Ming-Ying Shang; Guang-Xue Liu; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2016-09-13       Impact factor: 4.411

Review 9.  Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives.

Authors:  Masashi Tanaka; Satoshi Saito; Takayuki Inoue; Noriko Satoh-Asahara; Masafumi Ihara
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 10.  Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Masashi Tanaka; Satoshi Saito; Takayuki Inoue; Noriko Satoh-Asahara; Masafumi Ihara
Journal:  Int J Mol Sci       Date:  2020-03-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.